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Objective. Toinvestigatewhetherω-3fattyacidcouldstimulategastrointestinalmotilityafterabdominaloperation.Method.W istar
rats were randomly divided into 3 group (normal saline group, intralipid group, and ω-3 fatty acid group, n = 18/group)
after partial caecectomy and gastrostomosis, each group was divided into 3 groups (POD1, POD3, and POD6, n = 6/group).
Serum gastrin(GAS),motilin(MTL),interleukin-1 (IL-1),interleukin-6 (IL-6),tissuenecrosis factor-α (TNF-α), cyclooxygenase-
2 (COX-2), gastric emptying rate, and small bowel propulsion rate were measured. Results.O nP O D3 ,g a s t r i ce m p t y i n gr a t ea n d
small bowel propulsion rate in ω-3 fatty acid group were higher than those in normal saline group and intralipid group. Serum
GAS and MTL levels in ω-3 fatty acid group were higher than those in normal saline group, but serum IL-1, IL-6, TNF-α,a n d
COX-2 levels were lower than those in normal saline group and intralipid group. Conclusion. ω-3 fatty acid could accelerate the
recovery of gastrointestinal mobility after abdominal operation in rats, mainly by relieving postoperative inﬂammation.
1.Introduction
Early postoperative gastrointestinal motility dysfunction is
a frequent complication of laparotomy, especially after
gastrointestinal operation. It may cause small bowel obstruc-
tion, serious infection, hepatic dysfunction, or reoperation
with prolonged hospitalization and increased perioperative
expenses. In patients with treatment, continuous parenteral
nutrition or enteral feeding is necessary, but the outcomes of
such approaches are variable.
During parenteral nutrition or enteral nutrition, numer-
ous hormones secreted by the gut inﬂuence gastrointestinal
motor, and appear to contribute to the pathogenesis of
gastrointestinal motility dysfunction [1].
It is well established that manipulation of the bowel
induces the secretion of proinﬂammatory cytokines, includ-
ing interleukin-1 (IL-1), interleukin-6 (IL-6), and tissue
necrosis factor-α (TNF-α), and then to impaired muscle
function [2]. And cyclooxygenase-2 (COX-2) is the key
enzyme of prostaglandin synthesis in inﬂamed tissues. It
can aﬀect the motor activity of gastrointestinal tract in
postoperative ileus, and COX-2 inhibitors could help to
improve the outcome of this gut disorder [3, 4].
Supplementation of enteral nutritional formulas and
parenteral nutrition lipid emulsions with ω-3 fatty acid
could help reduce inﬂammation [5, 6], but the relationship
of ω-3 fatty acid and gastrointestinal motility still remains
unknown.
Our research was designed to study whether ω-3 fatty
acidcouldstimulategastrointestinal motilityafterabdominal
operation and its mechanisms of action.
2.Materialsand Methods
54 Wistar rats with the average body weight 250 ± 20g were
randomlydividedintonormal salinegroup,intralipidgroup,
and ω-3 fatty acid group (n = 18/group). Each group was
divided into POD 1 group, POD 3 group, and POD 6 group
(n = 6/group) according to the time of sacriﬁce.
Abdominal Operation. Wistar rats were anaesthetized
with 1% Pentobarbital (40mg/K). Then, opened the abdom-
inal cavity, partial caecectomy and gastrostomosis were2 Mediators of Inﬂammation
Table 1: Gastric emptying rate (%).
POD1 POD3 POD6
(1) normalsaline
group (n = 6) 24.70 ±2.73 34.82 ±3.02 46.48 ±3.25
(2) intralipid
group (n = 6) 24.58 ±2.54 37.32 ±2.01 47.90 ±2.21
(3) ω-3 fatty acid
group (n = 6) 24.62 ±2.32 40.35 ±1.9 347.33± 4.03
P (between group
1a n d3 ) 0.959 0.004∗ 0.740
P (between group
2a n d3 ) 0.974 0.044∗ 0.820
P (between group
1a n d2 ) 0.935 0.095 0.401
Table 2: Smallbowel propulsion rate (%).
POD1 POD3 POD6
(1) Normalsaline
group (n = 6) 35.27 ±3.09 40.48 ±2.71 53.93 ±2.49
(2) Intralipid
group (n = 6) 35.35 ±3.76 43.12 ±2.34 55.32 ±3.23
(3) ω-3 fatty acid
group (n = 6) 35.33 ±2.87 48.58 ±3.18 56.80 ±2.19
P (between group
1a n d3 ) 0.972 0.002∗ 0.164
P (between group
2a n d3 ) 0.992 0.008∗ 0.458
P (between group
1a n d2 ) 0.975 0.147 0.935
performed. The gastric feeding tube was ﬁxed on the back
of rats. Therefore, it closed the abdominal cavity and waited
for anaesthesia recovery.
T h er a t sw e r ep e r f u s e dn o r m a ls a l i n e( 1 2 . 5 m L / d ) ,
intralipid(12.5mL/d,5g/kg·d),orω-3fattyacid(12.5mL/d,
5g/kg·d) through gastric feeding tube after operation.
On POD 1, POD 3, and POD 6, the rat gastric emptying
rate, small bowel propulsion rate, serum gastrin (GAS), IL-
1, IL-6, TNF-α, COX-2 were measured with ELISA methods
(Uscnlife Science & Technoilgy Company, USA.). Serum
motilin (MTL) was measured with RIA methods. MTL
RIA kit (China institute of atomic energy, China) and
Multigamma 1261 instrument (Finland) were used.
Phenolsulfonphthalein paste (0.1mg/mL phenolsulfon-
phthalein, 10% gelatin) was injected into stomach through
stomach-tube 25min before rats were sacriﬁced. Gastric
emptying rate was measured by gastric phenolsulfonph-
thaleinemptying.Small bowel propulsionrate was measured
by small bowel phenolsulfonphthalein propulsion rate.
Continuous variables were compared using Student’s
t-test. P v a l u el e s st h a n. 0 5w a sc o n s i d e r e ds i g n i ﬁ c a n t .
Table 3: Serum GAS (pg/mL).
POD1 POD3 POD6
(1) normalsaline
group (n = 6) 93.78 ±19.21 122.25 ±18.78 153.58±26.74
(2) intralipid
group (n = 6) 92.00 ±12.13 150.75±20.301 51.55 ±26.27
(3) ω-3 fatty acid
group (n = 6) 94.67 ±17.46 156.68 ±22.10 154.23±20.93
P (between group
1a n d3 ) 0.849 0.002∗ 0.968
P (between group
2a n d3 ) 0.517 0.287 0.870
P (between group
1a n d2 ) 0.574 0.001∗ 0.900
Table 4: MTL (pg/mL).
POD1 POD3 POD6
(1) normalsaline
group (n = 6) 137.83±17.34 185.25±16.27 234.22±24.68
(2) intralipid
group (n = 6) 147.65±15.29 227.62±23.58 233.98±24.31
(3) ω-3 fatty acid
group (n = 6) 140.10±20.48 225.45 ±20.20 238.12±24.81
P (between group
1a n d3 ) 0.881 0.002∗ 0.835
P (between group
2a n d3 ) 0.301 0.880 0.561
P (between group
1a n d2 ) 0.384 0.029∗ 0.989
3.Results
(1) Gastric emptying rate, small bowel propulsion rate
(see Tables 1 and 2).
(2) Serum GAS and MTL levels (see Tables 3 and 4).
(3) Serum IL-1, IL-6,TNF-αlevels (see Tables 5,6, 7and
8).
OnPOD3,gastricemptyingrate,smallbowelpr opulsion
ratein ω-3 fatty acid groupwere higherthan those innormal
saline group and intralipid group. Serum IL-1, IL-6, TNF-α,
COX-2 levels in ω-3 fatty acid group were lower than those
in normal saline groupand intralipid group.Serum GASand
MTL levels in ω-3 fatty acid group were higher than those in
normal saline group.
4.Discussion
ω-3 fatty acid include Eicosapentaenoic acid (EPA), Ducosa-
hexaenoic acid (DHA), and Alpha-linolenic acid (ALA),
which play an important role in the regulation of inﬂamma-
tion [7].Mediators of Inﬂammation 3
Table 5: IL-1 (pg/mL).
POD1 POD3 POD6
(1) normalsaline
group (n = 6) 75.92 ±8.40 71.30 ±4.76 54.45 ±6.18
(2) intralipid
group (n = 6) 77.15 ±4.31 68.72 ±4.15 53.45 ±4.76
(3) ω-3 fatty acid
group (n = 6) 74.80 ±5.28 60.23 ±5.51 54.28 ±3.95
P (between group
1a n d3 ) 0.683 0.007∗ 0.941
P (between group
2a n d3 ) 0.366 0.004∗ 0.568
P (between group
1a n d2 ) 0.642 0.194 0.549
Table 6: IL-6 (pg/mL).
POD1 POD3 POD6
(1) normalsaline
group (n = 6) 201.70±22.58 217.97±32.631 43.70 ±30.79
(2) intralipid
group (n = 6) 215.83±32.48 216.63± 27.96 127.83±14.08
(3) ω-3 fatty acid
group (n = 6) 207.83±16.62 173.98± 12.76 142.22±20.64
P (between group
1a n d3 ) 0.545 0.015∗ 0.907
P (between group
2a n d3 ) 0.519 0.011∗ 0.216
P (between group
1a n d2 ) 0.325 0.672 0.347
The most important gastrointestinal hormones are GAS
and MTL. GAS is secreted from neuroendocrine G cells
which are principally located in the antrum of the stomach.
MTL is a hormone released by the endocrine cells of the
duodenal mucosa. They both can stimulate gastrointestinal
motility.
Our research showed that on POD 3, the serum GAS and
MTL levels in ω-3 fatty acid group were higher than those
in normal saline group, but there was no diﬀerence between
ω- 3f a t t ya c i dg r o u pa n di n t r a l i p i dg r o u p .T h i si n d i c a t e s
the mechanism that ω-3 fatty acid promotes the recovery of
gastrointestinal motility does not lie in the increase of serum
GAS and MTL levels. The possible reasons are as follows.
(1) Diﬀerent food has diﬀerent eﬀect on gastrointestinal
hormones. Both ω-3 fatty acid and intralipid belong to fatty
acids; their eﬀects to stimulating gastrointestinal hormones’
secretion are similar, but more powerful than normal saline.
(2) ω-3 fatty acid and intralipid can inhibit the secretion of
gastric acid, reduce PH value in stomach, then stimulate the
secretion of GAS. (3) ω-3 fatty acid and intralipid can also
stimulate the secretion of MTL.
As we know, intestinal handling induces the secretion
of IL-1, IL-6 and TNF-α, triggers mast cell activation and
inﬂammation associated with prolonged postoperative ileus.
Table 7: TNF-α (pg/mL).
POD1 POD3 POD6
(1) normalsaline
group (n = 6) 15.03 ±2.02 13.97± 1.86 9.75 ±1.58
(2) intralipid
group (n = 6) 15.57 ±1.77 14.83± 1.65 10.70 ±2.34
(3) ω-3 fatty acid
group (n = 6) 14.00 ±3.07 12.50± 1.70 9.87 ±1.43
P (between group
1a n d3 ) 0.439 0.007∗ 0.871
P (between group
2a n d3 ) 0.251 0.015∗ 0.255
P (between group
1a n d2 ) 0.603 0.672 0.347
Table 8: COX-2 (ng/mL).
POD1 POD3 POD6
(1) normalsaline
group (n = 6) 15.03 ±2.02 13.97± 1.86 9.75 ±1.58
(2) intralipid
group (n = 6) 15.57 ±1.77 14.83± 1.65 10.70 ±2.34
(3) ω-3 fatty acid
group (n = 6) 14.00 ±3.07 12.50± 1.70 9.87 ±1.43
P (between group
1a n d3 ) 0.439 0.007∗ 0.871
P (between group
2a n d3 ) 0.251 0.015∗ 0.255
P (between group
1a n d2 ) 0.603 0.672 0.347
COX-2 catalyzes the ﬁrst step of conversion of its common
substrate, arachidonic acid (AA), into a number of biolog-
ically active derivatives, designated as prostaglandins (PGs,
including PG-E2, PG-D2, PGF-2α,a n dP G - I 2 )a n dt h r o m -
boxane (TX) A2, which are major participants in rodent
postoperativeileus[8].In ourresearch, onPOD 3,theserum
IL-1, IL-6, TNF-α,C O X - 2l e v e l si nω-3 fatty acid group were
lowerthanthoseinnormalsalinegroupandintralipidgroup,
P<. 05. This indicates that ω-3 fatty acid can decrease
serum inﬂammatory factors and COX-2 levels. The possible
reasons are as follows. (1) After consumption, ω-3 fatty acid
can be incorporated into cell membranes and can reduce the
amount of AAavailableforthe synthesis ofproinﬂammatory
eicosanoids (e.g., PGs, leukotrienes (LTs)). Likewise, ω-3
fatty acid can also reduce the production of inﬂammatory
cytokines, such as IL-1, IL-6, and TNF-α [9]. (2) Withregard
toinﬂammatory processes, themainfattyacidsofinterestare
the AA, which is the precursor of inﬂammatory eicosanoids
like PG-E2 and LT-B4, but ω-3 fatty acid gives rise to
mediators (PG-E3, LT-B5) that are less inﬂammatory than
those produced from AA [10]. (3) In addition to modifying
the lipid mediator proﬁle, ω-3 fatty acid exerts eﬀects on
other aspects of inﬂammation like leukocytechemotaxis and
inﬂammatory cytokine production. Some of these eﬀects4 Mediators of Inﬂammation
are likely due to changes in gene expression, as a result of
altered transcription factor activity [10]. (4) COX-2 is the
keyenzyme of prostaglandin synthesis and ω-3 fatty acid can
reduce the expression of COX-2 mRNA, in this respect, ω-3
fatty acid could inhibit inﬂammation [11, 12]. (5) Recently,
resolvins and protectins, novel ω-3 fatty-acids-derived
mediators were identiﬁed [13]. These mediators can signal
for potent counter-regulatory eﬀects on leukocyte functions,
including preventing uncontrolled neutrophil swarming,
decreasing the generation of cytokines, chemokines, and
reactiveoxygenspeciesandpromotingclearanceofapoptotic
neutrophils from inﬂamed tissues [14]. In this way, ω-3 fatty
acids could reduce gastrointestinal inﬂammation.
Because postoperative inﬂammation inhibits gastroin-
testinal mobility signiﬁcantly, ω-3 fatty acid could accelerate
the recovery of gastrointestinal mobility after abdominal
operation.
Our study showed that enteral nutrition with ω-3 fatty
acid compared to intralipid could accelerate the recovery
of gastrointestinal mobility after caecectomy in rats. The
mechanism of action is that ω-3 fatty acid could decrease
serum inﬂammatory facts levels and relieve postoperative
inﬂammation. Hence, it can accelerate the recovery of
gastrointestinal mobility.
5.Conclusion
ω-3fattyacidcouldacceleratetherecoveryofgastrointestinal
mobility after abdominal operation in rats, mainly by
decreasingserumlevelsofIL-1,IL-6,TNF-α,andCOX-2and
by relieving postoperative inﬂammation.
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